UTMDのチャート
UTMDの企業情報
| symbol | UTMD |
|---|---|
| 会社名 | Utah Medical Products Inc. （ユタ・メディカル・プロダクツ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ユタ・メディカル・プロダクツ(Utah Medical Products Inc.)は病院用および使い捨ての医療機器の生産に従事する会社である。同社の製品カテゴリーには、胎児モニタリングアクセサリ、真空支援送達システム（VAD）、その他の労働および納品ツールを含む労働・配達/産科、DISPOSA-HOOD、DELTRAN PLUS及びGESCOを含む新生児集中治療、LINZシステム、FINESSE +ジェネレーター、EPITOME、PATHFINDER PLUS、HOLMIUMレーザーファイバー、LIBERTYシステム、ENDOCURETTE、TVUS / HSG-CathおよびLUMINを含む婦人科/泌尿器科/電気手術、DELTRAN使い捨て圧力トランスデューサ（DPT）を含む血圧モニタリング、並びに圧力監視アクセサリ、コンポーネントおよびその他の成形部品を含む。UTMDは、特に新生児集中治療室、労働派遣部門、病院の女性保健センター、外来診療所と医師の診療所に販売されている製品など、重要なケア分野で使用される医療機器を販売する。 ユタ・メディカル・プロダクツは、使い捨て用と病院用の医療機器を製造する米国のメ―カ―。製品は4部門に分類。産科は分娩管理ツ―ルなど。婦人科・電気外科・泌尿器科は、子宮疾患の切除・切開ツ―ル、尿失禁治療装置など。新生児集中治療は、病気の新生児向け治療装置など。血圧モニタ―・アクセサリ―・他は、部品などを他企業へOEMメ―カ―として販売する。 utah medical products, inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients. for more information about utah medical products, inc., visit utmd’s website at www.utahmed.com. |
| 本社所在地 | 7043 South 300 West Midvale UT 84047 USA |
| 代表者氏名 | Kevin L. Cornwell ケヴィン・L・コーンウェル |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer and Secretary |
| 電話番号 | +1 801-566-1200 |
| 設立年月日 | 1978年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 180人 |
| url | www.utahmed.com |
| nasdaq_url | https://www.nasdaq.com/symbol/utmd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 22.21400 |
| 終値（lastsale） | 89.3 |
| 時価総額（marketcap） | 333356900 |
| 時価総額 | 時価総額（百万ドル） 327.38410 |
| 売上高 | 売上高（百万ドル） 42.17800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 281.51110 |
| 当期純利益 | 当期純利益（百万ドル） 15.33900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Utah Medical Products Inc. revenues increased 4% to $21.9M. Net income before extraordinary items increased 10% to $8.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other income (expense) increase from $49K to $537K (income) Research and development decrease of 3% to $230K (expense). |
UTMDのテクニカル分析
UTMDのニュース
Utah Medical Products GAAP EPS of $1.15, revenue of $12.52M 2023/04/25 13:27:45 Seeking Alpha
Utah Medical Products press release (UTMD): Q1 GAAP EPS of $1.15.Revenue of $12.52M (+1.6% Y/Y).
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023 2023/04/25 13:00:00 GlobeNewswire
SALT LAKE CITY, UT, April 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - In the first calendar quarter (1Q) of 2023, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals previously announced for calendar year 2023.
Utah Medical Products Stock: Long-Term Gains On The Table (UTMD) 2023/04/19 08:29:48 Seeking Alpha
Utah Medical is a long-term compounder that was unfazed by the last two market cycles in 2002, 2008 and 2020. See why I reiterate a Buy rating on UTMD stock.
Utah Medical Products declares $0.295 dividend 2023/02/07 16:05:26 Seeking Alpha
Utah Medical Products (UTMD) declares $0.295/share quarterly dividend, in line with previous.
Utah Medical Products Reports Q4 EPS of $1.25 By Investing.com 2023/01/31 21:09:01 Investing.com
Utah Medical Products Reports Q4 EPS of $1.25
Utah Medical Products declares $0.295 dividend 2023/02/07 16:05:26 Seeking Alpha
Utah Medical Products (UTMD) declares $0.295/share quarterly dividend, in line with previous.
Utah Medical Products Reports Q4 EPS of $1.25 By Investing.com 2023/01/31 21:09:01 Investing.com
Utah Medical Products Reports Q4 EPS of $1.25
Utah Medical Products GAAP EPS of $1.25, revenue of $13.58M (NASDAQ:UTMD) 2023/01/31 14:23:48 Seeking Alpha
Utah Medical Products press release (UTMD): Q4 GAAP EPS of $1.25.Revenue of $13.58M (+5.2% Y/Y).
Utah Medical Products, Inc.: UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance 2023/01/31 14:06:00 Finanz Nachrichten
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which al…
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance 2023/01/31 14:00:00 GlobeNewswire
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allowed financial results for the year 2022 exceeding management’s beginning of year projections, despite many challenges.
Utah Medical Products declares $0.295 dividend 2023/02/07 16:05:26 Seeking Alpha
Utah Medical Products (UTMD) declares $0.295/share quarterly dividend, in line with previous.
Utah Medical Products Reports Q4 EPS of $1.25 By Investing.com 2023/01/31 21:09:01 Investing.com
Utah Medical Products Reports Q4 EPS of $1.25
Utah Medical Products GAAP EPS of $1.25, revenue of $13.58M (NASDAQ:UTMD) 2023/01/31 14:23:48 Seeking Alpha
Utah Medical Products press release (UTMD): Q4 GAAP EPS of $1.25.Revenue of $13.58M (+5.2% Y/Y).
Utah Medical Products, Inc.: UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance 2023/01/31 14:06:00 Finanz Nachrichten
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which al…
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance 2023/01/31 14:00:00 GlobeNewswire
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allowed financial results for the year 2022 exceeding management’s beginning of year projections, despite many challenges.